Download INS: Scientific Breakthroughs in Parkinson`s Disease

Saturday
Scientific Breakthroughs in
Parkinson’s Disease
CME: 3 hours
January 16, 2016
1:15 p.m.–4:15 p.m.
Program Director Aleksandar Videnovic, MD, MSc, Boston, MA
Program Description
Recent years have brought significant scientific developments to the forefront of Parkinson’s disease (PD). This
program will encompass selected and diverse scientific topics that have the potential to be transformative for
our understanding of PD pathophysiology, diagnosis, treatment, and disease modification. The program will cover
emerging concepts related to the similarities between PD and prion disorders with implications for PD treatment.
Opportunities and challenges for implementing stem cell based therapies for the treatment of PD will be discussed.
Advances in brain imaging and its role in the diagnosis, treatment, and monitoring of PD progression present a
tremendous resource to neurologists and other allied health professionals involved in the care of PD patients. Novel
developments in our understanding of the biological effects of exercise on neural circuitry emphasize the role of
exercise not only in day-to-day routine management, but also in slowing PD progression.
Learning Objectives
Recommended Audience
Upon completion, participants should be able to
understand the prion hypothesis of Parkinson’s disease;
discuss applications of stem cell based therapies in PD;
understand new developments in brain imaging of PD
and its implications in clinical care, disease progression,
and biomarker research; and understand the biological
effects of exercise in PD and its implications in
treatment and disease modification.
Trainee; General Neurologist; Specialist Neurologist;
Non-neurologist; Advanced Practice Provider
Core Competencies
Interpersonal and Communication Skills; Medical
Knowledge; Patient Care; Practice-based Learning
and Improvement
Schedule
1:15 p.m.–1:20 p.m.
Introduction
1:20 p.m.–2:00 p.m.
Is Parkinson’s Disease Prion Disease?
2:00 p.m.–2:40 p.m.
Human Stem Cell Based Therapies in Parkinson’s Disease: Past, Present, and Future
2:40 p.m.–3:20 p.m.
New Scientific Advances in Imaging of Parkinson’s Disease
3:20 p.m.–4:00 p.m.
Biological Effects of Exercise in Parkinson’s Disease: Implications for Disease Modification
and Clinical Care
Aleksandar Videnovic, MD, MSc, Boston, MA
Patrik Brundin, MD, PhD, Grand Rapids, MI
Ole Isacson, MD, Belmont, MA
Jennifer G. Goldman, MD, MS, Chicago, IL
Lisa M. Shulman, MD, FAAN, Baltimore, MD
4:00 p.m.–4:15 p.m.
Panel Discussion
Faculty
RECOMMENDED COMPANION COURSE – PAGE 15
Parkinson’s Disease: An Update on Motor and Non-motor Features, Current Treatments, and Clinical Trials in the
Pipeline
Fast, Easy Registration Online · AAN.com/view/breakthroughs 19